{"podcast":{"title":"Frankly Speaking About Family Medicine","slug":"frankly-speaking-about-family-medicine-434006","podcast_index_feed_id":434006,"rss_url":"https://feed.podbean.com/primedfranklyspeaking/feed.xml","website_url":"https://primedfranklyspeaking.podbean.com","image_url":"https://pbcdn1.podbean.com/imglogo/image-logo/13721080/PRM-123_DPL_mediaplayer_frankly-speaking_x7npub.jpg","author":"Pri-Med","episode_count":503,"summary":"A weekly Podcast series covering newsworthy topics in primary care medicine. Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com","last_synced_at":"2026-07-20T12:18:28.603391+00:00","page_url":"https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006"},"episode":{"title":"GLP-1 RAs and Hair Loss—Evaluating and Managing a Potential Side Effect - Frankly Speaking Ep 478","slug":"glp-1-ras-and-hair-loss-evaluating-and-managing-a-potential-side-effect-frankly-speaking-ep-478","published_at":"2026-03-30T05:30:00+00:00","page_url":"https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006/glp-1-ras-and-hair-loss-evaluating-and-managing-a-potential-side-effect-frankly-speaking-ep-478","show_page_url":"https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006","url":"https://primedfranklyspeaking.podbean.com/e/glp-1-ras-and-hair-loss%e2%80%94evaluating-and-managing-a-potential-side-effect-frankly-speaking-ep-478/","audio_url":"https://mcdn.podbean.com/mf/web/qq8nb6kiqp329xex/frankly-speaking-478-hair-loss-glp1prprojafr9w.mp3","summary":"Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-478 Overview: As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) become increasingly common in managing obesity, it is important for clinicians to recognize lesser-known adverse effects. This episode highlights the potential link between GLP-1 RAs and alopecia, equipping you to better evaluate, counsel, and manage patients reporting hair loss. Episode resource links: Alsuwailem OA, Alanazi R, Almutairi HM, Asiree RH, Almutairi W, Almutairi TM, Zamandar A, Alkhames S. Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review. Cureus. 2025 Sep 16;17(9):e92454. Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.","meta_description":"Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-478 Ov…","key_points":[],"chapters":[],"topics":[],"duration_seconds":572,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/frankly-speaking-about-family-medicine-434006/episodes/glp-1-ras-and-hair-loss-evaluating-and-managing-a-potential-side-effect-frankly-speaking-ep-478/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006/glp-1-ras-and-hair-loss-evaluating-and-managing-a-potential-side-effect-frankly-speaking-ep-478.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}